Purchase Order 75N92021P00048
Ended Awarded Last action
- Contract number
- 75N92021P00048
- Awardee
-
Ascella Biosystems Inc. UEI KNAZW3KFPY43
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $250,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
The National Heart Lung and Blood Institute (NHLBI), a civilian federal agency, awarded a $250,000 firm fixed-price purchase order to Ascella Biosystems Inc. on January 13, 2021, for support services under the RADX-TECH Work Package 1 initiative. The contract, which was not designated as a set-aside, carried an ultimate completion date of January 12, 2022, and identified performance location in Fremont, California. This award was designated as a National Interest Action related to coronavirus COVID-19 response efforts.
RADX-TECH (Rapid Acceleration of Diagnostics—Technology) is a National Institutes of Health program designed to accelerate the development, validation, and commercialization of COVID-19 diagnostic tests and technologies. Ascella Biosystems Inc. was selected to provide support services critical to advancing diagnostic capabilities during the pandemic response. The firm fixed-price structure and specific work package framework indicate a defined scope of deliverables aimed at strengthening the nation's diagnostic infrastructure during the emergency public health period.
Quick answers
Who was awarded contract 75N92021P00048?
75N92021P00048 was awarded to Ascella Biosystems Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on January 13, 2021.
How much is contract 75N92021P00048 worth?
The government has obligated $250,000 on 75N92021P00048.
Was contract 75N92021P00048 competed?
The extent of competition for 75N92021P00048 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award